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 52 
What is already known about this subject? 53 
 Patients with inflammatory bowel disease often have altered body composition. 54 
 The type and distribution of abdominal fat has been associated with complicated 55 
disease and poor postoperative outcomes in patients with inflammatory bowel 56 
disease. 57 
 58 
What are the new findings? 59 
 In patients with treatment refractory inflammatory bowel disease, abdominal body 60 
composition is characterised by excessive fat deposition and skeletal muscle 61 
deficits. 62 
 Physiological relationships between skeletal muscle mass with subcutaneous and 63 
visceral abdominal fat do not apply in inflammatory bowel disease or are reversed in 64 
such patients. 65 
 A larger body size is anticipated for the same anthropometry in patients with 66 
inflammatory bowel disease than healthy controls. 67 
 Pre-operative abdominal body composition is not predictive of post-operative 68 
outcomes. 69 
  70 
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Abstract 71 
Background: Abdominal fat type and distribution have been associated with 72 
complicated Crohn’s disease and adverse post-operative outcomes. There is a scarcity of 73 
studies which have assessed the abdominal distribution of fat and lean stores in patients 74 
with inflammatory bowel disease (IBD) and compared this with healthy controls.  75 
Objective: This retrospective study aimed to compare the abdominal body composition 76 
in IBD patients who failed medical treatment and who had Computed tomography (CT) 77 
imaging prior to gastrointestinal surgery with healthy controls. Associations between 78 
pre-operative abdominal body composition and post-operative outcomes within a year 79 
of surgery were explored. 80 
Participants/setting: Abdominal body composition was performed in 22, pre-surgical 81 
patients with medically refractory IBD (18 with Crohn’s disease) and 22 healthy 82 
controls, using routinely acquired CT. Total fat, subcutaneous fat, visceral fat, and 83 
skeletal muscle cross-sectional area were measured. 84 
Results: An independent disease effect was also observed explaining a fat deposition 85 
excess of 38 cm2 and a skeletal muscle deficit of 15 cm2 in IBD. Abdominal skeletal 86 
muscle correlated with visceral fat, for the control (rho=0.51, p=0.015), but not for the 87 
IBD group (rho=-0.13, p=0.553). A positive correlation observed between subcutaneous 88 
fat with skeletal muscle in the controls (rho=0.47, p=0.026), was reversed in the IBD 89 
group (rho=-0.43, p=0.045). Pre-operative abdominal body composition was not 90 
predictive of post-operative outcomes. 91 
Conclusions: A higher degree of abdominal adiposity, less skeletal mass and a larger 92 
body size is anticipated for the same anthropometry in IBD patients. Pre-operative 93 
abdominal body composition is not associated with surgical outcomes. 94 
 95 
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Introduction  99 
Alterations in the body composition of patients with IBD have been previously 100 
described from studies using bioelectrical impedance analysis and dual x-ray 101 
absorptiometry [1]. However, as conventional body composition constants, such as 102 
hydration level of lean mass, have been developed in health, but differ in IBD [2], 103 
methods (e.g. DXA, impedance, double labelled water) which consider these constants 104 
in the calculation of body composition might produce erroneous results. 105 
There are limited studies which have explored the segmental distribution of fat 106 
and lean stores in people with IBD using more sophisticated techniques. This is of 107 
particular importance as abdominal fat type and distribution has associated with 108 
aggressive disease [3] and infectious complications following bowel resection in 109 
Crohn’s disease [4]. In a recent retrospective study, abdominal myopenia was associated 110 
with primary nonresponse to biologics [5]. 111 
Computed tomography (CT) and magnetic resonance imaging are routinely 112 
undertaken in clinical practice in IBD patients. A CT scan obtained at the third lumbar 113 
vertebrae offers the possibility to measure directly body compartments such as 114 
abdominal skeletal muscle mass, subcutaneous and visceral adipose tissue [6,7]. 115 
The primary aim of this study was to assess the abdominal body composition 116 
characteristics in a group of IBD patients who have failed medical treatment and have 117 
had a CT scan prior to gastrointestinal surgery. A secondary aim was to explore 118 
associations between pre-operative abdominal body composition and post-operative 119 
outcomes, within a year of IBD surgery.  120 
  121 
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Subjects and methods  122 
Participants 123 
The electronic pathology database from the NHS of Greater Glasgow & Clyde was 124 
searched for all IBD patients who had undergone a gastrointestinal surgery for 125 
medically refractory IBD between the periods 2012 to 2013. The medical records were 126 
then searched to identify patients who underwent a pre-operative CT scan of abdomen 127 
and 22 (18 with Crohn’s disease and four with ulcerative colitis) were identified with 128 
anthropometry measurements available (Table 1). Disease characteristics, disease 129 
phenotype, prescribed medication and information on post-operative complications and 130 
incidence of clinical relapse within 12 months of operation were collected from the 131 
medical notes of the IBD participants (Table 1). Data on the postoperative 132 
complications were collected via review of the original surgical notes and notes of any 133 
surgical readmissions over the ensuing 12 months. The IBD patients had raised median 134 
concentration of CRP and low median serum albumin, indicating active systemic 135 
inflammatory response (Table 1). Two (9%) IBD patients had a BMI below 18.5 kg/m2 136 
(underweight) and two (9%) were obese (BMI>30 kg/m2).     137 
 A cohort of 22, patients who had CT studies due to acute abdominal pain and in 138 
whom no chronic or inflammatory pathology was found, was used as a control group. 139 
This group was selected from the same pathology database as the IBD group. None in 140 
the control group was underweight and 8 (36%) were obese (Table 1).  141 
 As this is a retrospective analysis of existing clinical data, no ethical committee 142 
review was required according to National Research Ethics Service guidance [8]. 143 
Assessment of body composition 144 
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Abdominal body composition was performed using CT images at the third lumbar 145 
vertebrae level. The images were analysed by two raters independently, as described 146 
previously [7]. In brief, the two raters defined the margins of the cross-sectional area 147 
(cm2) of each abdominal body composition compartment using the freeware program 148 
NIH ImageJ (version 1.48). Total fat (excluding intramuscular fat), subcutaneous fat, 149 
visceral fat, visceral-to-subcutaneous fat ratio and skeletal muscle cross-sectional area 150 
[3] were identified using the Hounsfield unit (HU) thresholds (adipose tissue: -190 to -151 
30; muscle: -29 to +150) [7]. An example is presented in Figure 1. 152 
Statistical analysis 153 
Differences in body composition compartments between the two groups were assessed 154 
with forward stepwise multivariate regression analysis. Univariate regression analysis 155 
was performed separately for each of the body composition compartments using a 156 
priori selected predictors (height, BMI, age and gender). Participant’s condition (i.e. 157 
control or IBD) was a fixed term. Predictors with a p-value<0.1 were entered one-by-158 
one in the multivariate model, starting with the one which was the most significant in 159 
univariate analysis. A final model was produced which included only significant 160 
predictors and the participant’s condition (i.e. control or IBD); thus the independent 161 
effect of IBD on body composition could be explored controlling at the same time for 162 
the effect of other confounders such as age, height, gender and BMI. Correlations 163 
among composition characteristics were explored with Spearman rho correlation. 164 
Associations between body composition with short-term post-operative complications 165 
and a clinical relapse event within 12 months of IBD surgery were explored with 166 
logistic regression analysis.  167 
10 
 
Results 168 
Predictors of abdominal body composition characteristics and the effect of IBD  169 
In multivariate analysis, BMI was the strongest positive predictor of visceral and 170 
subcutaneous fat and so was height for skeletal mass (Table 2). Each unit of BMI 171 
increase was associated with 9.4 of visceral and 10.7 cm2 increase of subcutaneous fat 172 
respectively. No such effect was found for skeletal muscle. Age was positively 173 
associated with visceral and subcutaneous fat (Table 2) and gender with skeletal muscle 174 
(Table 2). Females had on average 45 cm2 less muscle than males (Table 2). 175 
An independent effect of the participant’s condition (i.e. IBD or control) was 176 
observed for subcutaneous fat and skeletal muscle but not for visceral fat (Table 2). 177 
After accounting for the effect of other confounders, an excess of 38 cm2 for 178 
subcutaneous fat and a deficit of 15 cm2 for skeletal muscle mass was observed in IBD 179 
people compared with controls (Table 2). There were no significant correlations 180 
between the abdominal body composition characteristics of the IBD patients with 181 
measurements of plasma CRP or serum albumin (all p>0.05).   182 
 183 
Relationships among abdominal body composition characteristics 184 
Relationships between abdominal body composition characteristics are displayed in 185 
Figure 2. Visceral fat was positively correlated with subcutaneous fat for both groups 186 
(IBD: rho=0.62, p=0.002) vs Controls: rho=0.61, p=0.002). Abdominal skeletal muscle 187 
was positively associated with visceral fat for the control group only (IBD: rho=-0.13, 188 
p=0.553) vs Controls: rho=0.51, p=0.015). While a positive correlation was observed 189 
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between subcutaneous fat with skeletal muscle in the controls (rho=0.47, p=0.026), this 190 
relationship was reversed in IBD patients (rho=-0.43, p=0.045) (Figure 2). 191 
 192 
Pre-operative abdominal body composition characteristics and risk of post-operative 193 
complications and subsequent clinical relapse 194 
Eight participants (38%) presented a post-operative complications with the majority of 195 
them being wound infections (n=5), followed by anastomosis leak (n=2) and pelvic 196 
abscess (Table 1). Four patients relapsed within 12 months of operation. None of the 197 
abdominal body composition characteristics was predictive of an increased risk of post-198 
operative complications or a subsequent clinical relapse within 12 months of surgery 199 
(Table 3).    200 
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Discussion 201 
Patients with medically refractory IBD were characterised by deficits in abdominal 202 
skeletal muscle mass and an accrual of subcutaneous fat. No alterations were observed 203 
with regard to visceral fat. Together, these abdominal body composition characteristics 204 
are suggestive of features of nutritional cachexia similar to those seen in other 205 
inflammatory conditions, like cancer [9] and can be attributed to undernutrition, the 206 
effect of pro-inflammatory cytokines and steroid treatment [10]. 207 
The relationship between skeletal muscle and the two adipose tissue 208 
compartments, seen in controls, was absent or reversed in IBD. The exact mechanism of 209 
this association is unknown but it is likely to be multifactorial and to involve diminished 210 
physical activity in patients with active IBD, the effect of inflammatory cytokines on 211 
muscle mass[11] and protein metabolism[12], the excessive use of steroids or a primary 212 
role of visceral fat in the initiation of colonic inflammation [13,14]. A previous study 213 
showed that normalisation of BMI at 2 years follow-up was not been associated with an 214 
increment in fat free mass CD [15] and collectively this evidence suggests that BMI 215 
change might not be good proxy for body alterations in IBD.  216 
The clinical significance of these results should also be evaluated in the context 217 
of their ability to predict clinical outcomes. Previous research suggested an association 218 
between the visceral-to-subcutaneous fat ratio with post-operative complications [4] and 219 
disease severity [3] but this was not replicated in this small retrospective study of 220 
patients with medically refractory  disease, prior to gastrointestinal surgery. Patients 221 
with IBD are at a higher risk of adverse cardiovascular events [16] than the general 222 
population and based on the current findings, a higher degree of abdominal adiposity for 223 
a given BMI than healthy individuals should be expected. Thus clinical attention should 224 
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be given to the avoidance of overnutrition, particularly now that the epidemic of obesity 225 
is becoming common in IBD [17]. It might be that the focus on the dietetic support of 226 
IBD patients should be extended from the management of undernutrition to the 227 
prevention and correction of obesity and interventions with physical activity and 228 
exercise to improve muscle mass. 229 
 The strength of this study is the inclusion of an essentially healthy control group 230 
for first time [3,4], as well as the direct and independent assessment of each of the 231 
abdominal compartments. This is a major advantage compared to previous studies in 232 
IBD where measurement error in one body compartment might have propagated to the 233 
estimation of the others [1]. The main limitations are the small sample size, the 234 
heterogeneous patient population in terms of disease characteristics and the 235 
retrospective design of the study. Use of concomitant treatment following surgery may 236 
have also influenced the risk of post-operative complications and subsequent clinical 237 
relapse. Also, our control group was younger and had higher BMI than our IBD 238 
patients, which may have confounded the results of this study. However, instead of 239 
stratifying our analysis by these confounders, which would have compromised further 240 
statistical power and increase bias due to multiple testing, we chose to apply 241 
multivariate regression modelling to control for their effect. A lack of a biological 242 
association between adipose tissue with gender was not observed, but not unexpectedly, 243 
as our analysis was performed in a cross-section of the abdomen, and expressed in units 244 
of area, rather than as a percentage of the total area.      245 
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Conclusions  246 
Abdominal body composition characteristics in this study highlight the incidence of  247 
sarcopenia in medically refractory IBD patients. The significance of these findings in 248 
terms of clinical disease course and long-term outcomes of IBD should be explored in 249 
future prospective studies, particularly now that radiation-free MRI assessment is 250 
becoming more accessible and affordable. This study has clear implications for the 251 
nutritional assessment and management of people with IBD.  252 
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Figure Legends 253 
 254 
Figure 1: Abdominal body composition analysis using NIH ImageJ 255 
 256 
Panels: (a) The original CT image (b) the scale is set at a known distance (10 cm) from 257 
the original image, (c) definition of the total body fat area, applying the thresholds (-258 
190 to -30 HU) (d) definition of skeletal muscle area, after cropping the abdominal 259 
contents and L3 vertebrae and applying the thresholds (-29 to + 150 HU). 260 
 261 
Figure 2: Correlations among abdominal body characteristics in people with IBD and 262 
controls (blue circles: controls, brown squares: IBD) 263 
  264 
Panels: (a) Subcutaneous fat vs skeletal muscle: IBD: (rho: -0.43, p=0.045) vs 265 
Controls: (rho: 0.47, p=0.026); (b) Visceral fat vs skeletal muscle: (rho: -0.13, 266 
p=0.553) vs Controls (rho: 0.51, p=0.015); (c) Subcutaneous fat vs visceral fat; IBD: 267 
(rho: 0.61, p=0.002) vs Controls: (rho: 0.62, p=0.002)   268 
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Table 1: Participants characteristics 325 
 IBD 
(n=22) 
Healthy Controls 
(n=22) 
p-value 
*Disease location, n     
L1 6   
L2 8   
L3 4   
E1 1   
E2 1   
E3 2   
*Disease behaviour, n    
B1 6   
B2 + B2p 10   
B3 + B3p 6   
Treatment, n     
Aminosalicylates 13   
Steroids 16   
Thiopurines 7    
Biologics 7   
Type of surgery, n    
CD; colectomy   6   
CD; right hemicolectomy 9   
CD; left hemicolectomy 2   
CD; limited small bowel 1   
UC; subtotal colectomy 4   
Sex, males:females, n 12:10 12:10 1.000 
aAge, years 47.5 (33:63) 39.5 (30.8:45.5) 0.045 
19 
 
aBMI, kg/m2 23.6 (20.2:26.8) 27.3 (22.8:34.0) 0.037 
aHeight, m2 166.0 (156:175) 171 (165:180) 0.078 
aAlbumin, g/L 25 (23.0:30.5)   
aHaemoglobin, g/L 104.5 (98.5:121.2)   
aC-reactive protein, mg/L  66 (20:142)   
Post-operative complications  8   
Wound infection 5   
Anastomotic leak 2   
Pelvic abscess 1   
Number relapsed at 12 months 4   
a Median (inter-quartile range); CD: Crohn’s disease; UC: Ulcerative colitis; * disease 326 
phenotype based on the Montreal classification.  327 
  328 
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 329 
Table 2: Multivariate regression analysis of predictors of CT based abdominal body composition characteristics 330 
 Visceral fat (cm2) Subcutaneous fat (cm2) Skeletal muscle (cm2) Visc-to-subc ratio Total fat (cm2) 
β coefficient; p-value 
Gender, males NS NS 30; p<0.001 0.3; 18%; p=0.004 NS 
Age, years 1.6; p=0.004 1,1; p=0.038 NS NS 2.7; p=0.001 
BMI, kg/m2 9.4; p=<0.001 10.7; p<0.001 NS NS 20.1; p<0.001 
Height, cm2 NS NS 153; p<0.001 NS NS 
Condition, IBDa NS 38; p=0.035 -14.7; p=0.012 NS 62.7; p=0.019 
R2 of final 
modelb 
64% 65% 79% 18% 77% 
NS: non-significant; a participant condition (IBD or controls) was a fixed term in both univariate and multivariate regression analysis; visc-to-331 
subc fat ratio: ratio between visceral and subcutaneous fat area; b R2 coefficient of determination  332 
 333 
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 334 
 335 
Table 3: Pre-operative abdominal body composition characteristics and risk of post-336 
operative complications and subsequent clinical relapse at 12 months follow up 337 
 Post-operative 
complications 
Odd ratio, 95 CI 
p-
value 
 Relapse within 12 
months 
Odd ratio, 95% CI 
p-
value 
Visceral fat 1.00 (0.99 : 1.01) 0.433  1.00 (0.99 : 1.02) 0.386 
Subcutaneous fat 1.00 (0.99 : 1.01) 0.557  1.00 (0.99 : 1.02) 0.401 
Skeletal muscle 1.00 (0.98 : 1.02) 0.949  0.99 (0.96 : 1.03) 0.785 
Visc-to-subc 
ratio 
0.69 (0.06 : 8.6) 0.773  1.12 (0.06 : 21.7) 0.942 
Total fat 1.00 (1.00 : 1.01) 0.472  1.00 (1.00 : 1.01) 0.372 
 338 
 339 
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 340 
Figure 1 341 
 342 
  343 
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Figure 2 344 
 345 
